After the lockdown, ICMR plans to ask all states and UTs to send positive Covid-19 samples to study the genetic diversity of the virus, which it says will help India prepare better.
The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.
CSIR will launch trials to see if sepsis drug can stop Covid-19 from progressing in asymptomatic patients & if it can prevent it from redeveloping in recovered patients.
A round-up of the most important reports in major newspapers around the country – from TOI and HT, Express and The Hindu to The Telegraph, Mumbai Mirror and The Tribune, as well as top financial dailies.
In an exclusive interview to ThePrint, Union Health Minister Harsh Vardhan also said the government is aiming to test one lakh people per day by 31 May.
Of all academic institutions, it is at Harvard, the richest and perhaps the most powerful academic institution in the world, that Epstein’s ties appear to have flourished most.
Siddaramaiah govt’s five schemes strain finances as GST changes hit revenues; debt to jump nearly Rs 80,000 crore. State also plans to auction liquor licences & extend bar timings.
The MHA is deliberating on new recruitment rules for all CAPFs, including the CRPF, ITBP, and SSB. It wants to incorporate a 50% quota for Agniveers across the CAPFs.
If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.
COMMENTS